Cite
HARVARD Citation
Sivina, M. et al. (n.d.). The bruton tyrosine kinase inhibitor ibrutinib (PCI‐32765) blocks hairy cell leukaemia survival, proliferation and B cell receptor signalling: a new therapeutic approach. British journal of haematology. pp. 177-188. [Online].